Compare PETS & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PETS | ATCH |
|---|---|---|
| Founded | 1996 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4M | 29.6M |
| IPO Year | 2003 | 2024 |
| Metric | PETS | ATCH |
|---|---|---|
| Price | $1.21 | $0.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 130.2K | ★ 3.8M |
| Earning Date | 08-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $273,800,000.00 | $20,052,635.00 |
| Revenue This Year | N/A | $32.20 |
| Revenue Next Year | $2.24 | N/A |
| P/E Ratio | ★ N/A | $8.18 |
| Revenue Growth | N/A | ★ 84.70 |
| 52 Week Low | $1.15 | $0.16 |
| 52 Week High | $4.10 | $0.54 |
| Indicator | PETS | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 15.59 | 39.07 |
| Support Level | N/A | N/A |
| Resistance Level | $1.91 | $0.21 |
| Average True Range (ATR) | 0.04 | 0.01 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 3.70 | 6.27 |
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.